- Life sciences firm Danaher to buy Abcam in $5.7 bln deal Reuters.com
- Danaher to Buy Abcam in $5.7 Billion Deal. Investors Don’t Like the Premium. Barron’s
- Danaher to buy antibody expert Abcam for $5.7B FiercePharma
- Danaher to acquire Abcam for $24.00 per Share – Abcam plc Abcam plc
- Abcam’s (NASDAQ: ABCM) Stock Dips after Danaher Corp’s $5.7 Billion Acquisition Bid – TipRanks.com TipRanks
- View Full Coverage on Google News
Source link